Stock CYTO ALTAMIRA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
1.43 USD -4.03% Intraday chart for Altamira Therapeutics -6.54% -58.91%
May. 16 Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors CI
May. 01 Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 24.21B -
ARGENX SE Stock argenx SE
 22.78B -
GENMAB A/S Stock Genmab A/S
 17.96B
  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. Charts Altamira Therapeutics
  6. Sector Chart